Healthcare resource use of patients with transthyretin amyloid cardiomyopathy
Abstract Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM) is the cardiac manifestation of transthyretin amyloidosis (ATTR). The aim of this study was to estimate healthcare resource use for ATTR‐CM patients compared with heart failure (HF) patients, in Denmark, Finland, Norway, and Sweden. Method...
Saved in:
| Main Authors: | Rosa Lauppe, Johan Liseth Hansen, Anna Fornwall, Katarina Johansson, Mark H. Rozenbaum, Anne Mette Strand, Merja Vakevainen, Johanna Kuusisto, Einar Gude, J. Gustav Smith, Finn Gustafsson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | ESC Heart Failure |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ehf2.13913 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden
by: J Gustav Smith, et al.
Published: (2021-12-01) -
Hereditary transthyretin amyloidosis
by: T. A. Adyan, et al.
Published: (2020-01-01) -
Unravelling the myriad physiologic roles of transthyretin: critical considerations for treating transthyretin amyloidosis
by: Morie A. Gertz, et al.
Published: (2025-12-01) -
Uncovering cell type-specific phenotypes using a novel human in vitro model of transthyretin amyloid cardiomyopathy
by: Jiabin Qin, et al.
Published: (2025-07-01) -
Suspicion, screening, and diagnosis of wild‐type transthyretin amyloid cardiomyopathy: a systematic literature review
by: Katrine Bay, et al.
Published: (2022-06-01)